Lantus solostar 100 unit/ML 3ML
Ended Awarded
- Contract number
- SPE2DB25FZ6J9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,068
Award facts
- Contract value 100% obligated
- $3,068.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,068.40 by the Defense Logistics Agency (DLA) on April 22, 2025, with an ultimate completion date of April 23, 2025. The delivery order is for Lantus SoloStar 100 Unit/mL 3mL insulin pens, a diabetes medication supplied on a firm fixed price basis with no set-aside designation. This award represents a competitive, non-set-aside transaction within DLA's medical supply procurement framework and reflects AmerisourceBergen's role as a critical vendor for federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other medical commodities. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZ6J9?
SPE2DB25FZ6J9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2025.
How much is contract SPE2DB25FZ6J9 worth?
The government has obligated $3,068 on SPE2DB25FZ6J9.
Is contract SPE2DB25FZ6J9 an order under another contract?
Yes. SPE2DB25FZ6J9 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FZ6J9 competed?
The extent of competition for SPE2DB25FZ6J9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award